The Surprising Jobs With More-Than-Expected Ovarian Cancer The Surprising Jobs With More-Than-Expected Ovarian Cancer
When we can ' t explain something with genes or traditional risk factors, we turn to good old-fashioned epidemiology.Medscape (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 10, 2023 Category: Allergy & Immunology Tags: Internal Medicine Commentary Source Type: news
Ovarian cancer risk may be higher in seven popular professions, scientists warn
"Employment in certain occupations and specific occupational exposures may be associated with increased risks of ovarian cancer," researchers cautioned. (Source: Daily Express - Health)
Source: Daily Express - Health - July 10, 2023 Category: Consumer Health News Source Type: news
J & J Must Stop Claiming Plaintiff Support of $8.9B Talc Settlement
A federal bankruptcy judge ordered a lawyer for Johnson & Johnson to stop making unsubstantiated claims about support for an $8.9 billion settlement for talc victims without being able to back them up.
The order came during a multiday court hearing in late June in Trenton, New Jersey. Plaintiffs’ attorneys investigated Johnson & Johnson’s public statements that claimed the company had “secured commitments from over 60,000 current claimants” in support of the settlement.
Many plaintiffs claim Johnson’s Baby Powder and other products that contained toxic asbestos in their talcum powder caused ov...
Source: Asbestos and Mesothelioma News - July 10, 2023 Category: Environmental Health Authors: Walter Pacheco Tags: Asbestos Exposure Legal Source Type: news
Is There a Link Between Body Image and Polycystic Ovary Syndrome? Is There a Link Between Body Image and Polycystic Ovary Syndrome?
Punith Kempegowda, MD, PhD, MSc, MBBS, discusses body image concerns in women and individuals with polycystic ovary syndrome.Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 7, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news
Extra chromosomes —long a mystery in tumors—may help them grow
Cancer cells are sloppy with their DNA, often gaining entire chromosomes as they proliferate. Now, researchers have found that this extra DNA can rev up the cells' growth and stymie one of the body's main anticancer defenses. This chromosomal hoarding may leave some tumors susceptible to certain drugs, however, opening the possibility of tailored treatments.
The study, in which researchers used gene editing to compare cells with and without extra chromosomes, "is important, it's novel, and it was carried out in a very elegant way," says cell biologist Uri Ben-David of Tel Aviv University, who wasn't connected to the ...
Source: ScienceNOW - July 6, 2023 Category: Science Source Type: news
Woman who thought she was 'just obese' has ovarian cyst the size of a MEDICINE BALL removed
A 52-year-old woman in Italy had an 11-pound cyst removed from her ovary that weighed as much as a medicine ball. She had believed she was just obese. She also had a hysterectomy. (Source: the Mail online | Health)
Source: the Mail online | Health - July 2, 2023 Category: Consumer Health News Source Type: news
AI and CT facilitate opportunistic screening for enlarged spleen
Using a deep-learning AI algorithm and weight-based volumetric thresholds wit...Read more on AuntMinnie.comRelated Reading:
Deep-learning CT model helps predict ovarian cancer treatment response
Deep-learning model performs well with CEM images
FDA clears GE HealthCare's deep learning-based image processing software
Spleen stiffness correlates with cirrhosis complication
CT measurement detects splenomegaly (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 29, 2023 Category: Radiology Source Type: news
WHO Links Sweetener to Cancer; Younger-Age CRC Risk; PCOS and Ovarian Cancer
(MedPage Today) -- The World Health Organization's cancer research arm has concluded that the widely used artificial sweetener aspartame is "possibly carcinogenic to humans." (Reuters)
A large matched case-control study identified seven risk factors... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 29, 2023 Category: Hematology Source Type: news
They Got Cancer. Then Their Drugs Were Rationed
Halfway through her ovarian cancer treatment, Jennica Huff learned from her nurse practitioner there wasn’t enough drug to go around. Her therapy was being scaled back.#halfway #jennicahuff (Source: Reuters: Health)
Source: Reuters: Health - June 29, 2023 Category: Consumer Health News Source Type: news
Key Abstracts in Early Breast Cancer From ASCO 2023 Key Abstracts in Early Breast Cancer From ASCO 2023
Dr Harold Burstein highlights abstracts in early breast cancer from ASCO 2023, including the NATALEE trial of CDK4/6 inhibitor ribociclib and a meta-analysis on risk reduction with ovarian ablation.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 27, 2023 Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news
ENDO: Women With Polycystic Ovary Syndrome Experience More Body Image Concerns
TUESDAY, June 27, 2023 -- Women with polycystic ovary syndrome (PCOS) experience greater body image concerns than women without PCOS, according to research presented at the annual meeting of the Endocrine Society, held from June 15 to 18 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 27, 2023 Category: Pharmaceuticals Source Type: news
Women With PCOS Face Twice the Odds for Ovarian Cancer After Menopause
TUESDAY, June 27, 2023 -- The risk for ovarian cancer among women with polycystic ovary syndrome (PCOS) doubles after they go through menopause, new research discovers. “Our results and those from previous studies should be taken into account when... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 27, 2023 Category: General Medicine Source Type: news
Practice-Changing Data in Ovarian Cancer From ASCO 2023 Practice-Changing Data in Ovarian Cancer From ASCO 2023
Practice-changing data in platinum-resistant ovarian cancer, a novel triplet in unmutated disease, and long-term data on HIPEC are among highlights from ASCO 2023, chosen by Dr Susana Banerjee.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 26, 2023 Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news
Scientists Say They ’ve Reached Turning Point in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
More from TIME
[video id=W5jcvwLu autostart="viewable"]
“We’re getting something to work. Now we need to get...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
Scientists Say They ’ve Reached ‘Turning Point’ in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
“We’re getting something to work. Now we need to get it to work better,” said Dr. James Gulley, who help...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
